BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 27628325)

  • 1. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
    Wang HY; Rashidi HH
    Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a dual-color, double fusion FISH assay to detect RPN1/EVI1 gene fusion associated with inv(3), t(3;3), and ins(3;3) in patients with myelodysplasia and acute myeloid leukemia.
    Shearer BM; Sukov WR; Flynn HC; Knudson RA; Ketterling RP
    Am J Hematol; 2010 Aug; 85(8):569-74. PubMed ID: 20556821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.
    Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P
    Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia.
    Cui W; Sun J; Cotta CV; Medeiros LJ; Lin P
    Am J Clin Pathol; 2011 Aug; 136(2):282-8. PubMed ID: 21757602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26).
    Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C
    Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts.
    Martinelli G; Ottaviani E; Buonamici S; Isidori A; Borsaru G; Visani G; Piccaluga PP; Malagola M; Testoni N; Rondoni M; Nucifora G; Tura S; Baccarani M
    Haematologica; 2003 Nov; 88(11):1221-8. PubMed ID: 14607750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional cytogenetics and breakpoint distribution by fluorescent in situ hybridization in patients with malignant hemopathies associated with inv(3)(q21;q26) and t(3;3)(q21;q26).
    De Braekeleer E; Douet-Guilbert N; Basinko A; Bovo C; Guéganic N; Le Bris MJ; Morel F; De Braekeleer M
    Anticancer Res; 2011 Oct; 31(10):3441-8. PubMed ID: 21965759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study.
    Gong X; Yu T; Tang Q; Fu Y; Wu J; Zhu Y; Tu H; Ge H; Lu X; Gong D; Zhao X
    Int J Lab Hematol; 2019 Jun; 41(3):380-386. PubMed ID: 30793839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).
    Suzukawa K; Parganas E; Gajjar A; Abe T; Takahashi S; Tani K; Asano S; Asou H; Kamada N; Yokota J
    Blood; 1994 Oct; 84(8):2681-8. PubMed ID: 7919381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Aberrant EVI1 expression in acute myeloid leukaemia.
    Hinai AA; Valk PJ
    Br J Haematol; 2016 Mar; 172(6):870-8. PubMed ID: 26729571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inv(3)(q21q26)/t(3;3)(q21;q26) is frequently accompanied by alterations of the RUNX1, KRAS and NRAS and NF1 genes and mediates adverse prognosis both in MDS and in AML: a study in 39 cases of MDS or AML.
    Haferlach C; Bacher U; Haferlach T; Dicker F; Alpermann T; Kern W; Schnittger S
    Leukemia; 2011 May; 25(5):874-7. PubMed ID: 21283084
    [No Abstract]   [Full Text] [Related]  

  • 15. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.
    Yamazaki H; Suzuki M; Otsuki A; Shimizu R; Bresnick EH; Engel JD; Yamamoto M
    Cancer Cell; 2014 Apr; 25(4):415-27. PubMed ID: 24703906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
    Fonatsch C; Gudat H; Lengfelder E; Wandt H; Silling-Engelhardt G; Ludwig WD; Thiel E; Freund M; Bodenstein H; Schwieder G
    Leukemia; 1994 Aug; 8(8):1318-26. PubMed ID: 8057667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26).
    Suzukawa K; Taki T; Abe T; Asoh H; Kamada N; Yokota J; Morishita K
    Genomics; 1997 Jun; 42(2):356-60. PubMed ID: 9192861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid Neoplasms with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
    Rogers HJ; Hsi ED
    Surg Pathol Clin; 2013 Dec; 6(4):677-92. PubMed ID: 26839193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
    Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
    Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
    Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
    Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.